Search results
BREZTRI AEROSPHERE [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2022. 2. Rabe KF, Martinez FJ, Ferguson GT, et al. ETHOS Investigators. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD [article and supplementary appendix]. N Engl J Med. 2020;383(1):35-48. 3.
10 wrz 2017 · The INCONTROL 1 trial is a post-hoc, pooled analysis of three randomised, double-blind, double-dummy, parallel-group, multicentre trials of Symbicort pMDI in COPD. 1 Inclusion criteria were a clinical diagnosis of COPD, aged 40 or above, a pack-year history of ≥10 and one or more exacerbations experienced in the previous year. 2 The geometric ...
Get the latest AstraZeneca plc (AZN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Τ: (+30) 210 6871500, 800 11 68000 (χωρίς χρέωση) F: (+30) 210 6847968 Γ.Ε.ΜΗ. 638901000. E-mail: azgrcontactus@astrazeneca.com. AstraZeneca - Greece - Discover the ground-breaking work we are doing in Greece at AstraZeneca.com.
This offer is not conditioned on any past, present, or future purchase, including refills. Offer must be presented along with a valid prescription at the time of purchase. For additional details about this offer, please visit www.AIRSUPRAsavings.com. If you have any questions regarding this offer, please call 1-866-480-0030.
27 wrz 2023 · AZPIL. AstraZeneca Pharma India Limited (AZPIL) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are ...
AstraZeneca - Research-Based BioPharmaceutical Company
